Have We Finally Isolated A Pancreatic Cancer Biomarker?

Unlike some other cancer forms death rates from pancreatic cancer have been continuously raising due to a persistent absence of effective treatments beyond surgery. Inability to screen has also significantly limited progress-making for this tumor type. Typically by the time it’s diagnosed, it has already spread. The prestigious scientific journal Nature reported a new molecular study of… Read more »


To Be or Not to Be Small-Cell Lung Cancer?

Lung cancer, one of the most deadly killers worldwide, comprises two histological subtypes: small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). SCLC and NSCLC are classified as different diseases because of their distinct biology and genomic abnormalities; therefore therapeutic strategies for these two pathologies differ substantially. A recent review published by The Lancet Oncology… Read more »